Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesSimilar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 06/30/09
Rosenstock J et al. - The study shows no evidence of a greater risk of the development or progression of diabetic retinopathy with insulin glargine vs NPH insulin treatment in patients with type 2 diabetes mellitus.
Related Articles
Glyceraldehyde 3 phosphate dehydrogenase in retinal microvasculature: Implications for the development and progression of diabetic retinopathy
Investigative Ophthalmology and Visual Science, 11/18/09
Relevance Score: 69%
Identification of independent risk factors for the development of diabetic retinopathy requiring treatment
Acta Ophthalmologica, 11/18/09
Relevance Score: 69%
Diabetic Retinopathy Screening Update
Clinical Diabetes, 10/19/09
Relevance Score: 69%
Retinopathy - screening recommendations
Australian Family Physician, 10/06/09
Relevance Score: 69%
Micronutrients and Diabetic Retinopathy: A Systematic Review
Ophthalmology, 11/10/09
Relevance Score: 67%
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral transmucosal fentanyl citrate: a novel analgesic agent for use in retinal photocoagulation
Retina, 11/25/09
Short-Term Safety of 23-Gauge Single-Step Transconjunctival Vitrectomy Surgery
Retina, 11/25/09
Article Search
Sponsor